Clinical pharmacokinetics of aztreonam in cancer patients.

The pharmacokinetics of aztreonam were studied in 25 adult patients with hematological malignancies. Two groups of nine patients each received aztreonam (1 or 2 g every 8 h) prophylactically, and seven infected patients received a therapeutic regimen of aztreonam (1.5 g every 4 h). The mean peak ser...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Jones, P G, Bodey, G P, Swabb, E A, Ho, D H, Fainstein, V, Pasternak, J
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1984
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC179944/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6542763/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.26.4.455
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!